Helen F. Graham Cancer Center, Wistar establish Caspar Wistar Bacchieri Disparities Fellowship

Wistar, Accelerated Biosciences collaborate to develop immune cell therapies

The Wistar Institute is collaborating with Accelerated Biosciences Corp. to create a platform based on human trophoblast stem cells to explore new immunotherapies that use Accelerated Bio’s proprietary technology. This collaboration could generate various types of immune cells from hTSCs, changing the field of allogeneic immunotherapies.

July 12, 2024

Vol.50 No.28

In Brief

Jozef Madzo named director of bioinformatics at Wistar

Jozef Madzo was named director of bioinformatics at the Wistar Institute. He will lead and oversee Wistar’s bioinformatics projects and initiatives across a variety of advanced biomedical research programs.

July 05, 2024

Vol.50 No.27

In Brief

Noam Auslander receives $600K grant to identify connections between gut microbial genes and melanoma immunotherapy

The Wistar Institute’s Noam Auslander, assistant professor in the Molecular and Cellular Oncogenesis Program at the Ellen and Ronald Caplan Cancer Center, was awarded a $600,000 Women Scientists Innovation Award for Cancer Research grant from the V Foundation for Cancer Research.

June 28, 2024

Vol.50 No.26

Capitol Hill

House GOP leaders propose “streamlining” NIH into 15 institutes and centers
Plan calls for slashing ARPA-H, adding oversight to infectious disease research

Two Republican leaders in the House of Representatives have published a “framework” for reforming NIH—consolidating the agency’s 27 institutes and centers into 15—arguing that a fundamental rethinking of NIH’s structure would fix what they describe as a “system rife with stagnant leadership, as well as research duplication, gaps, and misconduct.”

June 21, 2024

Vol.50 No.25

By Matthew Bin Han Ong

In Brief

Wistar Institute receives $10M donation

The Wistar Institute received a $10 million donation from an anonymous donor who previously committed $20 million to support Wistar’s new Center for Advanced Therapeutics.

June 21, 2024

Vol.50 No.25

NCI Director's Report

NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines

After a year of lean appropriations, NCI is looking at what threatens to be a budgetary cataclysm—a potential 10-11% cut to the Labor-HHS spending bill in fiscal year 2025.

June 14, 2024

Vol.50 No.24

By Matthew Bin Han Ong

Helen F. Graham Cancer Center, Wistar establish Caspar Wistar Bacchieri Disparities Fellowship

YOU MAY BE INTERESTED IN

Wistar, Accelerated Biosciences collaborate to develop immune cell therapies

Jozef Madzo named director of bioinformatics at Wistar

Noam Auslander receives $600K grant to identify connections between gut microbial genes and melanoma immunotherapy

House GOP leaders propose “streamlining” NIH into 15 institutes and centers
Plan calls for slashing ARPA-H, adding oversight to infectious disease research

Wistar Institute receives $10M donation

NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines

Renew today!

Subscriber content

Login

Helen F. Graham Cancer Center, Wistar establish Caspar Wistar Bacchieri Disparities Fellowship

YOU MAY BE INTERESTED IN

Wistar, Accelerated Biosciences collaborate to develop immune cell therapies

Jozef Madzo named director of bioinformatics at Wistar

Noam Auslander receives $600K grant to identify connections between gut microbial genes and melanoma immunotherapy

House GOP leaders propose “streamlining” NIH into 15 institutes and centersPlan calls for slashing ARPA-H, adding oversight to infectious disease research

Wistar Institute receives $10M donation

NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines

Login

House GOP leaders propose “streamlining” NIH into 15 institutes and centers
Plan calls for slashing ARPA-H, adding oversight to infectious disease research